SCHEDULE: BlackRock Discloses 8.7% Stake in Baxter International
Beneficial Ownership Report
BlackRock Portfolio Management LLC has reported an 8.7% beneficial ownership stake in Baxter International Inc., totaling 44,925,341 common shares.
Summary
- BlackRock Portfolio Management LLC, on behalf of certain business units of BlackRock, Inc. and its subsidiaries and affiliates, reported beneficial ownership of 44,925,341 common shares of Baxter International Inc.
- This ownership represents 8.7% of Baxter International Inc.'s total outstanding common stock.
- BlackRock Portfolio Management LLC holds sole voting power over 44,289,706 shares and sole dispositive power over 44,925,341 shares.
- The aggregate ownership includes contributions from various BlackRock entities, with BlackRock Advisors, LLC specifically noted as beneficially owning 5% or greater of the outstanding shares.
Sentiment
Score: 5
Explanation: The filing is a standard regulatory disclosure of beneficial ownership by a large institutional investor, indicating a passive stake without any explicit positive or negative implications for the issuer's performance or strategy.
Positives
- The disclosure of a significant 8.7% stake by a major institutional investor like BlackRock may be perceived as a signal of confidence in Baxter International Inc.
Future Outlook
NA
Management Comments
- The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.
Industry Context
This Schedule 13G filing by BlackRock Portfolio Management LLC is a routine disclosure required when an institutional investor acquires more than 5% of a company's voting shares, but does not intend to influence or change control of the company. It provides transparency into significant passive ownership stakes by major asset managers like BlackRock, which manage vast portfolios across numerous public companies.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Authorized Signatories for SEC Filings (BlackRock Portfolio Management LLC) | Various individuals under Power of Attorney dated January 28, 2025 | Eric Andruczyk, Julie Ashworth, Richard Cundiff, R. Andrew Dickson, III, Spencer Fleming, Laura Hildner, David Maryles, Christopher Meade, Charles Park, James Raby, Daniel Riemer, David Rothenberg, Brenda Schulz and Joseph Virgilio | 2025-07-01 | Revocation of previous power of attorney and appointment of new attorneys-in-fact for BlackRock Portfolio Management LLC. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Update | BlackRock Portfolio Management LLC updated its Power of Attorney, revoking a previous one and appointing a new set of individuals as attorneys-in-fact to execute and file various SEC and non-U.S. regulatory documents on its behalf and its affiliates. | 2025-07-01 | This is a routine internal governance update for BlackRock Portfolio Management LLC, ensuring proper authorization for regulatory filings. It does not directly impact Baxter International's corporate governance. |
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake, which can be viewed as a vote of confidence or simply a portfolio allocation decision.
- Management: Awareness of a large passive shareholder, though BlackRock certifies it does not intend to influence control.
Key Dates
| Date | Description |
|---|---|
| 2025-01-28 | Previous Power of Attorney revoked by BlackRock Portfolio Management LLC. |
| 2025-07-01 | Effective date of the new Power of Attorney for BlackRock Portfolio Management LLC. |
| 2025-12-31 | Date of event which requires filing of this statement (reporting period end date). |
| 2026-01-21 | Signature date of the Schedule 13G filing by BlackRock Portfolio Management LLC. |
Keywords
BlackRock, Baxter International, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Healthcare, Medical Products
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.